Apontis Pharma AG
XETRA:APPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Apontis Pharma AG
Other Liabilities
Apontis Pharma AG
Other Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Apontis Pharma AG
XETRA:APPH
|
Other Liabilities
€8.2m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Other Liabilities
$47.2m
|
CAGR 3-Years
116%
|
CAGR 5-Years
90%
|
CAGR 10-Years
N/A
|
|
|
Bayer AG
XETRA:BAYN
|
Other Liabilities
€13.3B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-1%
|
|
|
Merck KGaA
XETRA:MRK
|
Other Liabilities
€2B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-5%
|
|
|
MPH Health Care AG
XETRA:93M1
|
Other Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dermapharm Holding SE
XETRA:DMP
|
Other Liabilities
€125.1m
|
CAGR 3-Years
8%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
Apontis Pharma AG
Glance View
APONTIS PHARMA AG engages in the development, promotion, and sale of single pills and other pharmaceutical products. The company is headquartered in Monheim Am Rhein, Nordrhein-Westfalen and currently employs 176 full-time employees. The company went IPO on 2021-05-11. The firm focuses on the commercialization of pharmaceutical products to General Practitioners and engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.
See Also
What is Apontis Pharma AG's Other Liabilities?
Other Liabilities
8.2m
EUR
Based on the financial report for Dec 31, 2024, Apontis Pharma AG's Other Liabilities amounts to 8.2m EUR.
What is Apontis Pharma AG's Other Liabilities growth rate?
Other Liabilities CAGR 5Y
-2%
Over the last year, the Other Liabilities growth was -49%. The average annual Other Liabilities growth rates for Apontis Pharma AG have been -5% over the past three years , -2% over the past five years .
